Summary:
This week on The Genetics Podcast, Patrick is joined by Justin Porcano, co-founder and Executive Director of Save Sight Now. They discuss how his daughter’s diagnosis with Usher syndrome type 1B (USH1B) inspired the founding of Save Sight Now, the organization’s efforts to accelerate research and overcome barriers in gene therapy, and the innovative gene delivery methods and therapeutic approaches currently in development.
Show Notes:
0:00 Intro to The Genetics Podcast
00:59 Welcome to Justin
01:39 How Justin’s daughter’s Usher syndrome diagnosis (USH1B) led to the founding of Safe Sight Now and a mission to accelerate research
05:23 Biggest hurdles to therapeutic development for USH1B
08:36 Progress in the research with new animal models and advances in clinical endpoint development
10:25 How Justin applied design thinking and AI to rapidly learn rare disease science
12:38 Advances in gene delivery approaches for USH1B
15:45 Therapeutic intervention windows in USH1B with early treatment for hearing loss and later options for addressing vestibular and visual impairments
18:32 Save Sight Now’s plans for the next phase of clinical translation and sustainable growth
20:50 Why Justin decided to establish Save Sight Now as an independent nonprofit
22:27 The need for stronger collaboration between patient organizations and biotech companies
25:50 Building global collaborations to expand Save Sight Now’s reach
28:00 How the community can support Save Sight Now’s mission and upcoming fundraising gala
28:59 Closing remarks
Find out more
Save Sight Now (https://www.savesightnow.org/)
Please consider rating and reviewing us on your chosen podcast listening platform!
https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link